Hemostatic alterations during coronary artery bypass grafting
Related Experiment Video
Updated: Mar 26, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Chantal L I Gielen1, Anneke Brand2, Waander L van Heerde3
1Dept. of Cardiothoracic Surgery, Leiden University Medical Center (LUMC), The Netherlands.
Insights
Cardiopulmonary bypass (CPB) in cardiac surgery reduces blood clotting factors and platelet function, but hemodilution is the main cause of bleeding post-CABG, not platelet activation.
Area of Science:
- Cardiovascular Surgery
- Hemostasis and Thrombosis
Background:
- Blood loss after cardiac surgery is multifactorial, involving surgical trauma and cardiopulmonary bypass (CPB).
- The specific contributions of CPB and surgical techniques to bleeding remain unclear.
Purpose of the Study:
- To investigate the impact of different cardiac surgery procedures on coagulation and fibrinolysis.
- To determine the primary causes of impaired hemostasis after coronary artery bypass grafting (CABG).
Main Methods:
- Compared three CABG groups: off-pump (OPCAB), CABG with CPB, and CABG with CPB plus aortic valve replacement (AVR).
- Assessed coagulation and fibrinolysis using flow cytometry, platelet aggregometry, thrombelastography, Nijmegen Hemostasis Assay, prothrombin fragment 1+2, and tissue plasminogen activator.
Main Results:
- CPB use decreased platelet counts, clot strength, fibrinogen, hematocrit, and albumin.
- Platelet aggregation was transiently impaired but recovered post-surgery; no perioperative platelet activation was observed.
- Increased tissue plasminogen activator and minor fibrinolysis occurred after reperfusion in CPB groups.
Conclusions:
- No significant platelet activation, dysfunction, or consumption was evident after cardiac surgery.
- Hemodilution associated with CPB was identified as the primary factor impairing hemostasis in patients receiving tranexamic acid.
- Coagulation parameters and platelet aggregation rebounded above baseline levels post-surgery.
Introduction:
The origination of blood loss after cardiac surgery is not fully explained, but is related to operation trauma and use of cardiopulmonary bypass (CPB). However, the extent of their contribution is incompletely known and might differ between distinct operation procedures.
Materials And Methods:
Three groups of CABG procedures were studied: 1) off-pump coronary artery bypass surgery (OPCAB, n=11) without CPB, 2) CABG with use of CPB (CABG, n=11) and 3) CABG with use of CPB combined with aortic valve replacement (AVR, n=11). Activation of coagulation and fibrinolysis was measured at various time points by flow cytometry, platelet aggregometry, thrombelastography, the Nijmegen Hemostasis Assay, prothrombin fragment 1+2 and tissue plasminogen activator.
Results And Conclusions:
The use of CPB during cardiac surgery decreased platelet counts, clot strength, fibrinogen, hematocrit and albumin concentrations during the procedure. No perioperative platelet activation was observed and functional (collagen induced) platelet aggregation was transiently impaired, but recovered after surgery in all groups. Patients operated with use of CPB showed increased tissue plasminogen activator concentrations after reperfusion followed by minor and transient fibrinolysis. After all types of surgery coagulation parameters and platelet aggregation showed a rebound above preoperative levels. To conclude, no evident platelet activation, dysfunction or consumption was demonstrated. In patients using tranexamic acid the most prominent factor impairing hemostasis after CABG surgery was hemodilution associated with CPB.
More Related Videos
09:12Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
12:00Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Vascular Spasm
Peripheral Artery Disease V: Postoperative Nursing Management